Table 1: Relative numbers of c-Fos (+) cells after MIF-1 treatment.
Structure abbreviationFigure 1 diagramStructureSalineicviv
cg1(1)(a)–(c)Cingulate cortex, area1 + a + a + + + + + c
cg2(2)(a)–(c)Cingulate cortex, area2 + a + a + + + + d
IL(1)(a)–(c)Infralimbic cortex+o + + b
DEn(1)(a)–(c)Dorsal endopiriform cortex + + + b ++ + + + d
CPu(1)(a)–(c)Caudate, putamen+o + + d
AcbC(1)(a)–(c)Accumbens nucleus, core++ + + + + + d
Pir(3)(a)–(c)Piriform cortex + + b + + b + + + b
PaDC(5)(a)–(c)Paraventricular hypothalamic nucleus, dorsal cap++++++ + + + + + d
PaLM(5)(a)–(c)Paraventricular hypothalamic nucleus, lateral magnocellular++++++ + + + + + d
PV(6)(a)–(c)Paraventricular thalamic nu++++ + + + + + d
PCom(7)(a)–(c)Nucleus of posterior commissure + + b + + + b
MCPC(7)(a)–(c)Magnocellular nucleus of posterior commissure+o + + b
RPF(7)(a)–(c)Retroparafascicular nucleuso+ + + b
PAG(7)(a)–(c)Periaqueductal gray + + + d + + b + + + + + d
IMD(6)(a)–(c)Intermed-dorsal thalamic nucleus + + + d + + b + + + + + d
BMA(6)(a)–(c)Basomedial amygdaloid nucleus, anterior+ + + b + + + c
o: absent immunoreactivity; +: low immunoreactivity; ++: modest immunoreactivity; +++: moderate immunoreactivity; ++++: dense immunoreactivity; +++++: very dense immunoreactivity. a: punctate immunoreactivity; b: sparse immunoreactivity; c: variable density; d: cluster of dense immunoreactivity.